Advertisement

Topics

Accentus Biologics Company Profile

19:36 EDT 23rd September 2018 | BioPortfolio

Accentus: First class specialists in process development and cGMP manufacture of biopharmaceuticals from microbial systems.

Location

F7 Culham
OX14 3ED
United Kingdom

Contact

Phone: 01235 464334
Fax: 01235 464289
Email: andrew.lewin@accentus.co.uk


News Articles [511 Associated News Articles listed on BioPortfolio]

WuXi Biologics to Invest $60 Million to Establish a Biologics Production Facility in the United ...

WuXi Biologics is a leading global platform company providing end-to-end solutions for biologics with a mission to accelerate and transform biologics discovery, development and manufacturing Read ...

WuXi Biologics' Chief Quality Officer Received Foreign Post Service Award from FDA

SHANGHAI, Sept. 17, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development...

Key Biologics merges with Astarte Biologics

In conjunction with the merger the new entity also received an investment from Ampersand Capital Partners to continue expanding the company in the rapidly evolving cell and gene therapy The post Key...

WuXi Biologics partners with Inhibrx for GMP manufacturing of protein─based therapeutics

WuXi Biologics, a leading global open─access biologics technology platform company offering end─to─end solutions for biologics discovery, development and manufacturing, and Inhibrx, Inc, a bioph...

DSM Biologics: Karen King on New Technology and Reducing the Cost of Medicines

In this episode of PharmaTelevision News Review, Fintan Walton talks with Karen King, President and Business Unit Director of DSM Biologics. Filmed at BioChicago 2010 in Chicago, USA, they discuss: ...

WuXi Biologics Announced Successful Completion of the First cGMP Run in MFG3

- One of the largest biologics clinical manufacturing facilities globally with 6 production lines which enable WuXi Biologics to complete 60 IND-enabling projects per year Read more...

AGC Biologics Cleared for Commercial Manufacture of Portola's FDA-Approved Andexxa

Drug Substance produced in AGC Biologics' facility in Bothell, Washington BOTHELL, Washington, May 24, 2018 /PRNewswire/ -- AGC Biologics, a global leader in clinical and commercial manufacturing ...

WuXi Biologics to establish $60m biologics manufacturing facility in Singapore

Chinese firm WuXi Biologics has announced a S$80m ($60m) investment to set up an a biologics manufacturing facility in Singapore.

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Standardized cat pelt [Jubilant HollisterStier LLC]

ALLERGENIC EXTRACT STANDARDIZED CAT PELT AP ACETONE PRECIPITATED

Standardized cat hair [Jubilant HollisterStier LLC]

ALLERGENIC EXTRACT STANDARDIZED CAT HAIR AP Acetone Precipitated

Cinryze [ViroPharma Biologics]

These highlights do not include all the information needed to use CINRYZE™ safely and effectively. See full prescribing information for CINRYZE.CINRYZE™ (C1 Esterase Inhibitor [Human]) For Intrave...

PubMed Articles [112 Associated PubMed Articles listed on BioPortfolio]

Biologics for pityriasis rubra pilaris treatment: a review of the literature.

Pityriasis rubra pilaris (PRP) is a rare inflammatory papulosquamous skin disease, often refractory to conventional therapies. The off-label use of biologics, such as anti-TNF, -IL-12/IL-23, -IL-17 ag...

Facilitated recruitment of mesenchymal stromal cells by bone marrow concentrate and platelet rich plasma.

Biologics containing growth factors are frequently used to enhance healing after musculoskeletal injuries. One mechanism of action is thought to be though the ability of biologics to induce homing and...

Persistence of treatment with biologics for patients with psoriasis: a real-world analysis of 16,545 biologic-naïve patients from the French national health insurance database (SNIIRAM).

Long-term clinical effectiveness of biologics in psoriasis is needed.

Biologics Monitoring: Incongruity between Recommendations and Clinician Monitoring Trends.

Biologics are a commonly used treatment for moderate to severe psoriasis. Monitoring laboratory test overuse provide little definitive benefit to patients.

Dosing considerations for inhaled biologics.

The number of biologics in the therapeutic development pipeline is increasing including those delivered though inhalation (Morales, 2017; Fathe, 2016). Biologics comprise a broad variety of complex ma...

Clinical Trials [76 Associated Clinical Trials listed on BioPortfolio]

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

The patients included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health plan...

Golimumab Safety and Surveillance Program Using the Ingenix NHI Database

The participants included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health ...

Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease

"RUN-CD" is an investigator initiated "Non interventional Trial" on biologics in Crohn´s Disease (CD) patients in Germany with a prospective documentation of effectiveness in induction an...

Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity

Rationale/hypothesis: Moderate-to-severe psoriasis can be treated with biologics. Objective To investigate whether the dose of biologics can be reduced in patients with psoriasis with sta...

Observational Study to Estimate the Effectiveness of Biologics When Treating Plaque Psoriasis

To estimate the real-world effectiveness of approved biologics in subjects with moderate-to-severe plaque psoriasis who are either starting or switching biologic medication.

Companies [263 Associated Companies listed on BioPortfolio]

Accentus Biologics

Accentus: First class specialists in process development and cGMP manufacture of biopharmaceuticals from microbial systems.

Accentus Medical

Accentus Medical is a leading medical technology company that combines a long history of expertise in surface coating and modification technologies with dedicated research and dev...

Accentus plc

Accentus is a leading developer of Intellectual Property and technology for licensing. We develop and commercialise innovative new ideas through our own in-house team of scientists and engineers and t...

ABEC and WuXi Biologics

WuXi Biologics, a Hong Kong-listed company, is the only open-access biologics technology platform in the world offering end-to-end solutions to empower organizations to discover d...

Burst Biologics

Burst Biologics is a rapidly growing Biotechnology Company and federally registered tissue bank located in Boise, Idaho. Burst Biologics is a developer of effective tissue process...

More Information about "Accentus Biologics" on BioPortfolio

We have published hundreds of Accentus Biologics news stories on BioPortfolio along with dozens of Accentus Biologics Clinical Trials and PubMed Articles about Accentus Biologics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Accentus Biologics Companies in our database. You can also find out about relevant Accentus Biologics Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record